We are live on ! Find out more
JPC

Jackson Park Capital Portfolio holdings

AUM $53.7M
1-Year Est. Return 6.17%
This Fund
S&P 500
This Quarter Est. Return
-2.2%
1 Year Est. Return
+6.17%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$73M
AUM Growth
-$4.55M
Cap. Flow
-$2.98M
Cap. Flow %
-4.08%
Top 10 Hldgs %
43.69%
Holding
54
New
13
Increased
6
Reduced
16
Closed
12

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$3.08M
2
GS icon
Goldman Sachs
GS
+$2.65M
3
MAR icon
Marriott International
MAR
+$2.21M
4
RHI icon
Robert Half
RHI
+$1.96M
5
SH icon
ProShares Short S&P500
SH
+$1.53M

Top Sells

Rank Stock Value
1
YHOO
Yahoo Inc
YHOO
+$2.4M
2
STJ
St Jude Medical
STJ
+$2.09M
3
COF icon
Capital One
COF
+$1.74M
4
RY icon
Royal Bank of Canada
RY
+$1.73M
5
JPM icon
JPMorgan Chase
JPM
+$1.5M

Sector Composition

Rank Sector Weight
1 Financials 32.66%
2 Healthcare 15.71%
3 Consumer Discretionary 12.07%
4 Communication Services 9.35%
5 Energy 8.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NLSN
26
DELISTED
Nielsen Holdings plc
NLSN
$1.3M 1.78%
25,000
-8,000
-24% -$422K
NOV icon
27
NOV
NOV
$7.48B
$1.25M 1.71%
+37,000
New +$1.19M
CELG
28
DELISTED
Celgene Corp
CELG
$1.18M 1.62%
+12,000
New +$1.24M
TDG icon
29
TransDigm Group
TDG
$65.6B
$1.05M 1.45%
4,000
-1,000
-20% -$244K
TIF
30
DELISTED
Tiffany & Co.
TIF
$1.03M 1.41%
17,000
– –
ARMK icon
31
Aramark
ARMK
$15.3B
$1M 1.37%
41,550
-18,005
-30% -$433K
TROW icon
32
T. Rowe Price
TROW
$23.7B
$949K 1.3%
+13,000
New +$968K
AXP icon
33
American Express
AXP
$225B
$851K 1.17%
14,000
-1,000
-7% -$63.3K
JAZZ icon
34
Jazz Pharmaceuticals
JAZZ
$15.9B
$848K 1.16%
6,000
– –
EXPE icon
35
Expedia Group
EXPE
$39.5B
$797K 1.09%
7,500
+500
+7% +$54.3K
AME icon
36
Ametek
AME
$54.2B
$624K 0.86%
13,500
+4,500
+50% +$216K
BHC icon
37
Bausch Health
BHC
$2.36B
$423K 0.58%
+21,000
New +$595K
RWM icon
38
ProShares Short Russell2000
RWM
$104M
$295K 0.4%
+5,000
New +$303K
KIN
39
DELISTED
Kindred Biosciences, Inc.
KIN
$273K 0.37%
77,000
– –
FMI
40
DELISTED
Foundation Medicine, Inc.
FMI
$233K 0.32%
12,500
– –
NBRV
41
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$195K 0.27%
+104
New +$210K
ATYR
42
aTyr Pharma
ATYR
$53M
$183K 0.25%
+4,714
New +$219K
J icon
43
Jacobs Solutions
J
$17.8B
– –
-24,179
Closed -$871K
MSM icon
44
MSC Industrial Direct
MSM
$6.66B
– –
-7,000
Closed -$534K
OUT icon
45
Outfront Media
OUT
$5.21B
– –
-21,335
Closed -$443K
PYPL icon
46
PayPal
PYPL
$45.9B
– –
-22,000
Closed -$849K
RY icon
47
Royal Bank of Canada
RY
$283B
– –
-30,000
Closed -$1.73M
UNP icon
48
Union Pacific
UNP
$183B
– –
-11,000
Closed -$875K
MON
49
DELISTED
Monsanto Co
MON
– –
-10,000
Closed -$877K
STJ
50
DELISTED
St Jude Medical
STJ
– –
-38,000
Closed -$2.09M
1
2
3

Similar funds

FNYS
First New York Securities New York $53.7M AUM 57.01% 1-Year Est. Return
OL
Orbitronix LP Newport Beach, California $54.2M AUM 17.92% 1-Year Est. Return
NAM
Nichols Asset Management Sudbury, Massachusetts $51M AUM 5.34% 1-Year Est. Return
BC
BHR Capital New York $48.6M AUM 3.78% 1-Year Est. Return
IWC
Integrated Wealth Counsel Carmel, California $46.5M AUM 7.34% 1-Year Est. Return
RCI
Redwood Capital Investments Hanover, Maryland $43.1M AUM 25.43% 1-Year Est. Return
PCM
Pyrrho Capital Management New York $66.5M AUM 7.14% 1-Year Est. Return
GCP
Glen Capital Partners Waltham, Massachusetts $68.9M AUM 21.81% 1-Year Est. Return

Jackson Park Capital's Q2 2016 Portfolio in Review

As of Q2 2016, Jackson Park Capital held 54 positions worth $73M, down 5.9% from $77.5M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Jackson Park Capital withdrew a net $2.98M in Q2 2016, closing 12 positions and reducing 16 holdings. Its most notable exit was St Jude Medical, an estimated $2.09M position sold in full.

By sector, the portfolio is most concentrated in Financials at 33% of assets, down from 36% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Jackson Park Capital opened a new position in Biogen worth $2.83M.

  • Jackson Park Capital's largest Q2 2016 buy was Biogen: 11,700 shares worth $2.83M.
  • Jackson Park Capital added most to Alphabet (Google) Class C in Q2 2016, an estimated $646K increase.
  • Jackson Park Capital's biggest Q2 2016 reduction was Yahoo Inc, cutting an estimated $2.4M.
  • Jackson Park Capital fully exited St Jude Medical in Q2 2016, selling an estimated $2.09M.
  • Jackson Park Capital's ten largest holdings make up 44% of its $73M portfolio in Q2 2016.
  • Jackson Park Capital opened 13 new positions and closed 12 in Q2 2016.
  • Jackson Park Capital's portfolio value fell 5.9% quarter-over-quarter to $73M.

Based on Jackson Park Capital's 13F filing for Q2 2016, filed 28 Jul 2016.